Lipocine (LPCN) Misses Q2 EPS by 41c

Lipocine (NASDAQ: LPCN) reported Q2 EPS of ($0.41). Revenue for the quarter came in at $620 thousand.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Nebius soars on second quarter revenue beat
• Kamada Ltd. (KMDA) Tops Q2 EPS by 4c
• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance